Related Experiment Video
Updated: Jul 7, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
beta-Sitosterol induces G2/M arrest, endoreduplication, and apoptosis through the Bcl-2 and PI3K/Akt signaling
Dong-Oh Moon1, Mun-Ock Kim, Yung Hyun Choi
1Faculty of Applied Marine Science, Cheju National University, Jeju Special Self-Governing Province 690-756, South Korea.
Abstract:
beta-Sitosterol (SITO) is a potentially valuable candidate for cancer chemotherapy, however the cellular and molecular mechanisms responsible for its anti-cancer activity are unknown. Therefore, we attempted to elucidate the mechanisms responsible for SITO-induced anti-proliferation in human leukemia cells. Treatment with SITO increased caspase-3 activation and DNA fragmentation in U937 and HL60 cells. This effect was associated with significant G2/M arrest and endoreduplication. We also demonstrated that SITO treatment significantly increases levels of polymeric alpha-tubulin and promoted microtubule polymerization. We next elucidated that ectopic expression of Bcl-2 accelerates endoreduplication in U937 cells. Furthermore, the specific Bcl-2 inhibitor, HA14-1, prevented endoreduplication through G2 phase arrest. Interestingly, SITO treatment did not significantly promote endoreduplication or decrease cell viability in Bcl-2 null K562 cells. SITO treatment also induced a gradual increase of phosphatidyl-inositol 3-kinase (PI3K) and Akt phosphorylation. Treatment with the selective PI3K/Akt inhibitor LY29004 completely blocked endoreduplication and apoptosis in the presence of SITO. In addition, treatment with SITO-induced phosphorylation of extracellular signal-regulated protein kinase (ERK), however significance of ERK activation in the execution of apoptosis and endoreduplication is unknown. These results suggest that SITO induces endoreduplication by promoting spindle microtubule dynamics through the Bcl-2 and PI3K/Akt signaling pathways.
Insights
Beta-Sitosterol (SITO) shows anti-cancer potential by inducing endoreduplication and apoptosis in leukemia cells. It promotes microtubule polymerization via Bcl-2 and PI3K/Akt pathways, offering a novel therapeutic strategy.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Beta-Sitosterol (SITO) is a phytosterol with potential anticancer properties.
- The specific molecular mechanisms underlying SITO's anti-leukemia effects are largely unknown.
Purpose of the Study:
- To elucidate the cellular and molecular mechanisms of SITO-induced anti-proliferation in human leukemia cells.
- To investigate the role of Bcl-2 and PI3K/Akt signaling pathways in SITO's effects.
Main Methods:
- Treatment of U937, HL60, and K562 leukemia cell lines with SITO.
- Analysis of caspase-3 activation, DNA fragmentation, cell cycle arrest, and endoreduplication.
- Assessment of alpha-tubulin polymerization and signaling pathway activation (Bcl-2, PI3K/Akt, ERK).
Main Results:
- SITO induced caspase-3 activation, DNA fragmentation, G2/M arrest, and endoreduplication in leukemia cells.
- SITO promoted microtubule polymerization and increased Bcl-2 and PI3K/Akt phosphorylation.
- Bcl-2 and PI3K/Akt pathways were crucial for SITO-induced endoreduplication and apoptosis.
Conclusions:
- SITO exerts anti-leukemia effects by promoting endoreduplication and apoptosis.
- These effects are mediated by enhanced spindle microtubule dynamics through the Bcl-2 and PI3K/Akt signaling pathways.
More Related Videos
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
11:13Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
Related Concept Videos
The Intrinsic Apoptotic Pathway
Negative Regulator Molecules
Inhibition of Cdk Activity
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle